Related Experiment Video

Updated: Jan 16, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.2K

Characterisation of the Novel HLA-C*07:1179 Allele by PacBio Sequencing

Yanbo Nie1, Yue Hou1, Chuting Zhao1

  • 1Sino-US Diagnostics Lab, Tianjin Enterprise Key Laboratory of AI-Aided Hematopathology Diagnosis, Tianjin, China.

HLA
|September 26, 2025
PubMed
Abstract

None:

HLA-C*07:1179 differs from HLA-C*07:02:01:01 by one nucleotide substitution at position 710 in exon 4.

Keywords:
HLA‐C*07:1179PacBio sequencingnew allele

More Related Videos

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.1K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

Related Experiment Videos

Last Updated: Jan 16, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.2K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.1K
Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

17.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.9K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K

Articles linked to this work by shared authors, journal, and citation graph.

Acute myeloid leukemia with 4q12 rearrangements involving CHIC2: "pitfalls" in fluorescence in situ hybridization diagnosis of PDGFRA rearrangements.

American journal of clinical pathology·2026

The Novel HLA Class II Allele, HLA-DPA1*02:167, Identified by PacBio Sequencing.

HLA·2026

Adverse outcomes and high incidence of therapy-related neoplasms in patients with the t(16;21)/RUNX1::RUNX1T3 fusion.

Leukemia & lymphoma·2025

A case report of mixed-phenotype acute leukemia with atypical BCR::ABL1 e13a3 fusion gene.

Medicine·2025

Tertiary lymphoid structures correlate with the therapeutic efficacy and prognosis of resectable esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy plus immunotherapy.

Frontiers in immunology·2025

Tertiary lymphoid structures in esophageal cancer: a novel target for immunotherapy.

Frontiers in immunology·2025

Characterisation of the Novel HLA-DRB1*14:02:13 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-C*06:390 Allele by Next-Generation Sequencing.

HLA·2026

The Novel HLA-B*51:397 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual.

HLA·2026

Identification of the Null Allele HLA-A*23:157N Characterised by a Two Nucleotide Insertion in Exon 3.

HLA·2026

Detection of the Novel HLA-A*01:522 Allele by Next-Generation Sequencing in a Brazilian Individual.

HLA·2026

Characterisation of the Novel HLA-C*08:334 Allele in a Brazilian Volunteer Donor.

HLA·2026

RETRACTED: Frolli et al. Executive Functions and Foreign Language Learning. Pediatr. Rep. 2022, 14, 450-456.

Pediatric reports·2026

Hoarseness as a Manifestation of Chronic Lymphocytic Leukaemia Involving the Larynx.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026

From Pathogenicity to Mechanism: A Variant Interpretation Framework for Monogenic Epilepsy.

Clinical genetics·2026

A case report of crossed aphasia, grasping, and intermanual conflict with the left hand.

Neurocase·2026

Discovery of the Novel HLA-C*08:01:44 Allele in a Taiwanese Individual.

HLA·2026

Polymorphism in Exon 5 Defines the Novel HLA-E*01:156 Allele.

HLA·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us